BridgeMD
New treatment option for End Stage Renal Disease
Official title The Effect of Intradialytic Eye Exercise in Hemodialysis Patients
ClinicalTrials.gov ID: NCT07591714
What this study is testing
- What it's testing
- This pilot randomized trial will evaluate whether a structured intradialytic eye-exercise program can be delivered safely and consistently during maintenance hemodialysis and whether it shows preliminary promise for improving physical function, balance, and fall-related concern. The study is needed because hemodialysis patients commonly experience impaired physical performance, reduced balance, and fear of falling, and these problems are associated with higher fall risk; at the same time, supervised exercise during dialysis is increasingly viewed as a practical way to reach this medically complex and often sedentary population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults ≥18 years receiving maintenance in-center hemodialysis
- Clinically stable for brief seated intradialytic intervention
- Able to understand and follow eye-exercise instructions
- Able to provide informed consent
- Able to sit upright independently during dialysis
You likely can't join if
- Unstable cardiac conditions (e.g., unstable angina, recent myocardial infarction, decompensated heart failure, uncontrolled arrhythmia)
- Active infection or acute medical illness
- Hemodynamic instability
- Significant cognitive or communication impairment preventing instruction-following
- Severe uncorrected visual impairment or active ocular disease
- Recent major ophthalmologic surgery
See the full eligibility criteria
- Adults ≥18 years receiving maintenance in-center hemodialysis
- Clinically stable for brief seated intradialytic intervention
- Able to understand and follow eye-exercise instructions
- Able to provide informed consent
- Able to sit upright independently during dialysis
- Able to complete repeated outcome assessments
- Able to communicate discomfort or adverse symptoms
- Usual corrective lenses permitted if needed for visual clarity
- Unstable cardiac conditions (e.g., unstable angina, recent myocardial infarction, decompensated heart failure, uncontrolled arrhythmia)
- Active infection or acute medical illness
- Hemodynamic instability
- Significant cognitive or communication impairment preventing instruction-following
- Severe uncorrected visual impairment or active ocular disease
- Recent major ophthalmologic surgery
- Severe musculoskeletal or neurologic limitations preventing participation or testing
- Any condition deemed unsafe for intradialytic exercise by the treating physician or nephrologist
The study team makes the final eligibility decision.
Where it's taking place
- Isfahan, Iran
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Isfahan, Iran. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.